Inflammatory human leucocyte antigen genotypes are not a risk factor in chronic subdural hematoma development
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Inflammatory human leucocyte antigen genotypes are not a risk factor in chronic subdural hematoma development. / Jensen, Thorbjørn Søren Rønn; Fugleholm, Kåre; Ekstrøm, Claus Thorn; Bruunsgaard, Helle.
In: Acta Neurochirurgica, Vol. 165, 2023, p. 2399–2405.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Inflammatory human leucocyte antigen genotypes are not a risk factor in chronic subdural hematoma development
AU - Jensen, Thorbjørn Søren Rønn
AU - Fugleholm, Kåre
AU - Ekstrøm, Claus Thorn
AU - Bruunsgaard, Helle
N1 - Publisher Copyright: © 2023, The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.
PY - 2023
Y1 - 2023
N2 - Background: Chronic subdural hematoma (CSDH) pathophysiology has undergone a paradigm shift from being regarded as solely traumatic to be driven mainly by inflammation. Human leucocyte antigen (HLA) is a gene complex involved in antigen processing and presentation to T lymphocytes, thereby mediating the adaptive immune responses. As specific HLA profiles are associated with inflammatory diseases, patients with a specific HLA profile may have a lower threshold for subdural inflammation, and therefore are predisposed for CSDH development. We hypothesized that (1) CSDH patients have a specific HLA profile compared to a Danish background population, and (2) patients with recurrent CSDH have a specific HLA profile compared to CSDH patients without recurrent CSDH. Methods: Three specific HLA class II haplotypes known to drive inflammatory-mediated diseases were determined in 68 patients with CSDH. The distribution of these three haplotypes in our CSDH population was compared to a Danish population of blood donors using Monte Carlo Pearson’s chi-square test. Furthermore, the distribution of the haplotypes was compared between CSDH patients with and without recurrent CSDH. Results: We found no significant association between either of the haplotypes and the risk of CSDH, and neither of the haplotypes were associated with increased risk of CSDH recurrence. Conclusion: This study did not show an association between selected HLA class II haplotypes and the risk of CSDH or recurrence of CSDH compared with a healthy background population.
AB - Background: Chronic subdural hematoma (CSDH) pathophysiology has undergone a paradigm shift from being regarded as solely traumatic to be driven mainly by inflammation. Human leucocyte antigen (HLA) is a gene complex involved in antigen processing and presentation to T lymphocytes, thereby mediating the adaptive immune responses. As specific HLA profiles are associated with inflammatory diseases, patients with a specific HLA profile may have a lower threshold for subdural inflammation, and therefore are predisposed for CSDH development. We hypothesized that (1) CSDH patients have a specific HLA profile compared to a Danish background population, and (2) patients with recurrent CSDH have a specific HLA profile compared to CSDH patients without recurrent CSDH. Methods: Three specific HLA class II haplotypes known to drive inflammatory-mediated diseases were determined in 68 patients with CSDH. The distribution of these three haplotypes in our CSDH population was compared to a Danish population of blood donors using Monte Carlo Pearson’s chi-square test. Furthermore, the distribution of the haplotypes was compared between CSDH patients with and without recurrent CSDH. Results: We found no significant association between either of the haplotypes and the risk of CSDH, and neither of the haplotypes were associated with increased risk of CSDH recurrence. Conclusion: This study did not show an association between selected HLA class II haplotypes and the risk of CSDH or recurrence of CSDH compared with a healthy background population.
KW - Chronic subdural hematoma
KW - Genetic disposition
KW - Human leucocyte antigen
U2 - 10.1007/s00701-023-05745-w
DO - 10.1007/s00701-023-05745-w
M3 - Journal article
C2 - 37550524
AN - SCOPUS:85166910530
VL - 165
SP - 2399
EP - 2405
JO - Acta Neurochirurgica
JF - Acta Neurochirurgica
SN - 0001-6268
ER -
ID: 362681598